Form 4 for QXL QUANTUM X LABS INC.
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-04 · accession 0001493152-26-009797 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-12 | 2026-03-04 | QXL | Yoresh Eliyahu | Dir | P - Purchase | — | +179.2K | 347.3K | +107% | — |
| D | 2026-03-12 | 2026-03-04 | QXL | Yoresh Eliyahu | Dir | P - Purchase | — | +88.7K | 88.7K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2026-03-04 | P | A | 179,159 | — | 347,276 | D | — | — | (F1) On March 4, 2026, the Reporting Person acquired (i) 179,159 shares of common stock of Viewbix Inc. ("Common Stock") and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 88,675 shares of Common Stock, in exchange for the Reporting Person's shares in Quantum X Labs Ltd. ("Quantum"), pursuant to a Securities Exchange Agreement dated December 15, 2025 by and between the Issuer, Quantum and shareholders of Quantum, which included the Reporting Person (the "Securities Exchange Agreement'). The transactions contemplated by the Securities Exchange Agreement were pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. |
| 2 | Derivative | Pre-Funded Warrant to purchase common stock | 2026-03-04 | P | A | 88,675 | — | 88,675 | D | $0.00 · 2026-03-04 to — | 88,675 Common Stock | (F1) On March 4, 2026, the Reporting Person acquired (i) 179,159 shares of common stock of Viewbix Inc. ("Common Stock") and (ii) pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 88,675 shares of Common Stock, in exchange for the Reporting Person's shares in Quantum X Labs Ltd. ("Quantum"), pursuant to a Securities Exchange Agreement dated December 15, 2025 by and between the Issuer, Quantum and shareholders of Quantum, which included the Reporting Person (the "Securities Exchange Agreement'). The transactions contemplated by the Securities Exchange Agreement were pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. (F3) The Pre-Funded Warrants will not expire until exercised in full. |